IL6 and rheumatoid arthritis: Treating these mice with an IL-21R.Fc fusion protein reduced the clinical signs of collagen-induced arthritis, decreased antibody levels and decreased IL-6 levels thereby demonstrating a pathogenic role for IL-21 in mouse models of RA (16).